- 作者：Hanna Uosukainen ; J. Simon Bell ; Kirsti Laitinen ; Ulrich Tacke ; Jenni Ilom?ki ; Juha H.O. Turunen
- 关键词：Buprenorphine-naloxone ; Community pharmacy ; Opioid substitution treatment
- 刊名：The International Journal of Drug Policy
- 出版年：2013
- 出版时间：September, 2013
- 年：2013
- 卷：24
- 期：5
- 页码：492-497
- 全文大小：392 K
Background
Finnish community pharmacies have been permitted to dispense buprenorphine-naloxone since February 2008. This study explored the dispensing practices, service experiences, problems encountered and opportunities for future development.Methods
In August 2011, a questionnaire was mailed to all Finnish community pharmacies dispensing buprenorphine-naloxone (n = 69).
Results
Sixty-four pharmacies responded (93 % ), of which 54 had dispensed buprenorphine-naloxone to 155 clients since 2008. Forty-eight pharmacies had 108 current clients (10 % of all buprenorphine-naloxone clients in Finland). Overall satisfaction with buprenorphine-naloxone dispensing was high, with all respondents indicating dispensing had gone ¡®well¡¯ or ¡®very well¡¯. Fourteen pharmacies (26 % ) had experienced one or more problems, predominately in relation timing or non-collection of doses. Problems were more common in pharmacies with more than one buprenorphine-naloxone client (odds ratio 1.39, 95 % confidence interval 1.05-1.86). Most pharmacies (n = 43, 80 % ) identified opportunities for improvement, including the need for more education and financial remuneration. Forty-six pharmacies (85 % ) were willing to dispense buprenorphine-naloxone to more clients; however, 43 pharmacies (80 % ) perceived that supervision of buprenorphine-naloxone dosing is not a suitable task for pharmacists in Finland.
Conclusion
Provision of buprenorphine-naloxone in Finnish community pharmacies has remained relatively small-scale. As experiences have been generally positive and problems rare, it may be possible to expand these services.